Chapter PDF
Similar content being viewed by others
Keywords
- Severe Acute Respiratory Syndrome
- Severe Acute Respiratory Syndrome
- Severe Acute Respiratory Syndrome CORONAVIRUS
- Severe Acute Respiratory Syndrome Coronavirus
- Severe Acute Respiratory Syndrome Infection
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Peiris JS, Lai ST, Poon LL, et al. SARS study group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361:1319-25 (2003).
Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 348:1967-76 (2003).
Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med. 349:2431-41 (2003).
Tanaka F, Abe M, Akiyoshi T, et al. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector. Cancer Res. 57:1335-43 (1997).
Okada M, Yoshimura N, Kaieda T, Yamamura Y, Kishimoto T. Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc Natl Acad Sci U S A. 78:7717-21 (1981).
deMello DE, Mahmoud S, Padfield PJ, Hoffmann JW. Generation of an immortal differentiated lung type-II epithelial cell line from the adult H-2K(b)tsA58 transgenic mouse. In Vitro Cell Dev Biol Anim. 36:374-82 (2003).
Gao W, Tamin A, Soloff A, et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet. 362:1895-6 (2003).
Yang ZY, Kong WP, Huang Y, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 428:561-4 (2004).
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426:450-4 (2003).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Okada, M. et al. (2006). Development of Vaccines and Passive Immunotherapy Against Sars Coronavirus Using Mouse and Scid-PBL/hu Mouse Models. In: Perlman, S., Holmes, K.V. (eds) The Nidoviruses. Advances in Experimental Medicine and Biology, vol 581. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-33012-9_102
Download citation
DOI: https://doi.org/10.1007/978-0-387-33012-9_102
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-26202-4
Online ISBN: 978-0-387-33012-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)